Type of Publication: | Journal article |
Publication status: | Published |
URI (citable link): | http://nbn-resolving.de/urn:nbn:de:bsz:352-2-1syym271fngfm8 |
Author: | Amelio, Ivano; Melino, Gerry; Levine, Arnold J. |
Year of publication: | 2021 |
Published in: | Molecular Oncology ; 15 (2021), 7. - pp. 1759-1763. - Wiley. - ISSN 1574-7891. - eISSN 1878-0261 |
Pubmed ID: | 33942515 |
DOI (citable link): | https://dx.doi.org/10.1002/1878-0261.12977 |
Summary: |
Three collaborative studies published by the groups of Vogelstein, Gabelli, and Zhou report the development of specially designed bispecific antibodies that may help in overcoming the limitations of current immunotherapies. The bispecific antibodies have been designed to couple cells harboring HLA-presented tumor-specific antigens from Tp53 mutant or Ras mutant with CD4 and CD8 T cells, thus facilitating immune-mediated clearance of the cancer cells.
|
Subject (DDC): | 570 Biosciences, Biology |
Link to License: | Attribution 4.0 International |
Refereed: | Yes |
AMELIO, Ivano, Gerry MELINO, Arnold J. LEVINE, 2021. Bispecific antibodies come to the aid of cancer immunotherapy. In: Molecular Oncology. Wiley. 15(7), pp. 1759-1763. ISSN 1574-7891. eISSN 1878-0261. Available under: doi: 10.1002/1878-0261.12977
@article{Amelio2021Bispe-56464, title={Bispecific antibodies come to the aid of cancer immunotherapy}, year={2021}, doi={10.1002/1878-0261.12977}, number={7}, volume={15}, issn={1574-7891}, journal={Molecular Oncology}, pages={1759--1763}, author={Amelio, Ivano and Melino, Gerry and Levine, Arnold J.} }
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/rdf/resource/123456789/56464"> <dcterms:abstract xml:lang="eng">Three collaborative studies published by the groups of Vogelstein, Gabelli, and Zhou report the development of specially designed bispecific antibodies that may help in overcoming the limitations of current immunotherapies. The bispecific antibodies have been designed to couple cells harboring HLA-presented tumor-specific antigens from Tp53 mutant or Ras mutant with CD4 and CD8 T cells, thus facilitating immune-mediated clearance of the cancer cells.</dcterms:abstract> <dcterms:title>Bispecific antibodies come to the aid of cancer immunotherapy</dcterms:title> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/rdf/resource/123456789/28"/> <dc:creator>Amelio, Ivano</dc:creator> <foaf:homepage rdf:resource="http://localhost:8080/jspui"/> <dc:creator>Melino, Gerry</dc:creator> <dc:rights>Attribution 4.0 International</dc:rights> <dc:contributor>Levine, Arnold J.</dc:contributor> <dc:contributor>Melino, Gerry</dc:contributor> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/rdf/resource/123456789/28"/> <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2022-02-09T10:46:54Z</dc:date> <dcterms:issued>2021</dcterms:issued> <dc:language>eng</dc:language> <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/56464/3/Amelio_2-1syym271fngfm8.pdf"/> <dc:creator>Levine, Arnold J.</dc:creator> <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/56464"/> <dc:contributor>Amelio, Ivano</dc:contributor> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2022-02-09T10:46:54Z</dcterms:available> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/56464/3/Amelio_2-1syym271fngfm8.pdf"/> </rdf:Description> </rdf:RDF>
Amelio_2-1syym271fngfm8.pdf | 85 |